Recombinant Human BAFF Protein，His

BAFF (B-cell activating factor), also known as BLyS (B lymphocyte stimulator), is a crucial cytokine in the regulation of B-cell survival, differentiation, and proliferation. Its importance in the immune system has made it a significant target for research, particularly in the context of autoimmune diseases and cancers, where BAFF is often found to be dysregulated. Elevated levels of BAFF are associated with several conditions, including systemic lupus erythematosus (SLE) and other B-cell malignancies, leading to increased B-cell survival and altered immune responses. Researchers have aimed to develop recombinant BAFF proteins to better understand its biological functions and to explore therapeutic applications. These studies often involve the characterization of BAFF’s interactions with its receptors, BAFF-R, TACI, and BCMA, which play distinct roles in B-cell biology. Understanding these interactions provides insights into the signaling pathways that govern B-cell homeostasis and can reveal potential targets for drug development. Moreover, recombinant BAFF proteins can serve as tools to evaluate immune responses in preclinical models, paving the way for innovative treatments that modulate BAFF levels for therapeutic benefits in autoimmune diseases and related disorders. As such, research on BAFF recombinant proteins is not only pivotal for elucidating the underlying mechanisms of B-cell regulation but also holds promise for the advancement of novel therapeutic strategies.